BMRN
Price
$55.43
Change
-$0.14 (-0.25%)
Updated
Oct 3 closing price
Capitalization
10.64B
16 days until earnings call
JAZZ
Price
$139.48
Change
+$2.27 (+1.65%)
Updated
Oct 3 closing price
Capitalization
8.46B
30 days until earnings call
Interact to see
Advertisement

BMRN vs JAZZ

Header iconBMRN vs JAZZ Comparison
Open Charts BMRN vs JAZZBanner chart's image
BioMarin Pharmaceutical
Price$55.43
Change-$0.14 (-0.25%)
Volume$2.36M
Capitalization10.64B
Jazz Pharmaceuticals
Price$139.48
Change+$2.27 (+1.65%)
Volume$1.05M
Capitalization8.46B
BMRN vs JAZZ Comparison Chart in %
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. JAZZ commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a StrongBuy and JAZZ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (BMRN: $55.43 vs. JAZZ: $139.48)
Brand notoriety: BMRN and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 103% vs. JAZZ: 131%
Market capitalization -- BMRN: $10.64B vs. JAZZ: $8.46B
BMRN [@Biotechnology] is valued at $10.64B. JAZZ’s [@Biotechnology] market capitalization is $8.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, JAZZ is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 4 TA indicator(s) are bullish while JAZZ’s TA Score has 4 bullish TA indicator(s).

  • BMRN’s TA Score: 4 bullish, 5 bearish.
  • JAZZ’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а +2.93% price change this week, while JAZZ (@Biotechnology) price change was +9.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

BMRN is expected to report earnings on Oct 22, 2025.

JAZZ is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than JAZZ($8.46B). BMRN has higher P/E ratio than JAZZ: BMRN (16.35) vs JAZZ (15.38). JAZZ YTD gains are higher at: 13.260 vs. BMRN (-15.670). BMRN has higher annual earnings (EBITDA): 934M vs. JAZZ (372M). JAZZ has more cash in the bank: 1.67B vs. BMRN (1.43B). BMRN has less debt than JAZZ: BMRN (604M) vs JAZZ (5.43B). JAZZ has higher revenues than BMRN: JAZZ (4.09B) vs BMRN (3.06B).
BMRNJAZZBMRN / JAZZ
Capitalization10.6B8.46B125%
EBITDA934M372M251%
Gain YTD-15.67013.260-118%
P/E Ratio16.3515.38106%
Revenue3.06B4.09B75%
Total Cash1.43B1.67B86%
Total Debt604M5.43B11%
FUNDAMENTALS RATINGS
BMRN vs JAZZ: Fundamental Ratings
BMRN
JAZZ
OUTLOOK RATING
1..100
1033
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
6594
PRICE GROWTH RATING
1..100
7944
P/E GROWTH RATING
1..100
9875
SEASONALITY SCORE
1..100
506

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (65) in the Biotechnology industry is in the same range as JAZZ (73) in the Pharmaceuticals Other industry. This means that BMRN’s stock grew similarly to JAZZ’s over the last 12 months.

JAZZ's Profit vs Risk Rating (97) in the Pharmaceuticals Other industry is in the same range as BMRN (100) in the Biotechnology industry. This means that JAZZ’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (65) in the Biotechnology industry is in the same range as JAZZ (94) in the Pharmaceuticals Other industry. This means that BMRN’s stock grew similarly to JAZZ’s over the last 12 months.

JAZZ's Price Growth Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for BMRN (79) in the Biotechnology industry. This means that JAZZ’s stock grew somewhat faster than BMRN’s over the last 12 months.

JAZZ's P/E Growth Rating (75) in the Pharmaceuticals Other industry is in the same range as BMRN (98) in the Biotechnology industry. This means that JAZZ’s stock grew similarly to BMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNJAZZ
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
72%
Momentum
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
59%
MACD
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
65%
Advances
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 3 days ago
60%
Declines
ODDS (%)
Bearish Trend 13 days ago
62%
Bearish Trend 10 days ago
57%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CCMG31.430.15
+0.49%
CCM Global Equity ETF
UGA62.230.27
+0.44%
United States Gasoline
RBIL50.100.01
+0.03%
F/m Ultrshrt Trs Infl-Protd Sec TIPS ETF
QIG45.44N/A
N/A
WisdomTree US Corporate Bond
MQT10.04-0.06
-0.59%
Blackrock Muni Yield Quality Fund II

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.25%
TECH - BMRN
48%
Loosely correlated
+1.39%
SYRE - BMRN
47%
Loosely correlated
-0.56%
JAZZ - BMRN
46%
Loosely correlated
+1.65%
ROIV - BMRN
45%
Loosely correlated
+1.19%
IDYA - BMRN
45%
Loosely correlated
+1.62%
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with BMRN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
+1.65%
BMRN - JAZZ
45%
Loosely correlated
-0.25%
AMLX - JAZZ
43%
Loosely correlated
+0.98%
TECH - JAZZ
43%
Loosely correlated
+1.39%
FTRE - JAZZ
41%
Loosely correlated
-1.56%
ROIV - JAZZ
40%
Loosely correlated
+1.19%
More